{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:13:35Z","timestamp":1790374415778,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T00:00:00Z","timestamp":1722729600000},"content-version":"vor","delay-in-days":125,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["23FC1041"],"award-info":[{"award-number":["23FC1041"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["22K16406"],"award-info":[{"award-number":["22K16406"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jsbmb.2024.106462","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T02:06:01Z","timestamp":1705284361000},"page":"106462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Histopathological analysis of tumor microenvironment in adrenocortical carcinoma: Possible effects of in situ disorganized glucocorticoid production on tumor immunity"],"prefix":"10.1016","volume":"238","author":[{"given":"Yuki","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Tezuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Omata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikiyo","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Tokodai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiyoshi","family":"Fujishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Kawanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuyuki","family":"Katabami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ikeya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Oki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nanjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitoshi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Unno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2024.106462_bib1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2024.106462_bib2","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1002\/cncr.23886","article-title":"Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors","volume":"113","author":"Bilimoria","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jsbmb.2024.106462_bib3","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1245\/s10434-020-09562-8","article-title":"Cumulative GRAS score as a predictor of survival after resection for adrenocortical carcinoma: analysis from the US adrenocortical carcinoma database","volume":"28","author":"Baechle","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jsbmb.2024.106462_bib4","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2024.106462_bib5","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2024.106462_bib6","first-page":"13","article-title":"Understanding mitotane mode of action","volume":"68","author":"Waszut","year":"2017","journal-title":"J. Physiol. Pharm."},{"key":"10.1016\/j.jsbmb.2024.106462_bib7","doi-asserted-by":"crossref","first-page":"R325","DOI":"10.1530\/ERC-15-0318","article-title":"Developing treatment for adrenocortical carcinoma","volume":"22","author":"Kerkhofs","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.jsbmb.2024.106462_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-018-0424-9","article-title":"Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial","volume":"6","author":"Le Tourneau","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jsbmb.2024.106462_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-019-0722-x","article-title":"Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma","volume":"7","author":"Habra","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jsbmb.2024.106462_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1200\/JCO.19.01586","article-title":"PD-1 blockade in advanced adrenocortical carcinoma","volume":"38","author":"Raj","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2024.106462_bib11","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s40618-020-01306-5","article-title":"The role of immune checkpoint inhibitor therapy in advanced adrenocortical carcinoma revisited: review of literature","volume":"43","author":"Brabo","year":"2020","journal-title":"J. Endocrinol. Invest"},{"key":"10.1016\/j.jsbmb.2024.106462_bib12","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.eururo.2013.11.006","article-title":"Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer","volume":"65","author":"Berruti","year":"2014","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jsbmb.2024.106462_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1530\/EJE-18-0450","article-title":"Influence of hormonal functional status on survival in adrenocortical carcinoma: systematic review and meta-analysis","volume":"179","author":"Vanbrabant","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2024.106462_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0046-8177(93)90088-X","article-title":"Steroidogenesis in human adrenocortical carcinoma: biochemical activities, immunohistochemistry, and in situ hybridization of steroidogenic enzymes and histopathologic study in nine cases","volume":"24","author":"Sasano","year":"1993","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jsbmb.2024.106462_bib15","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1210\/js.2019-00305","article-title":"Response to immunotherapy in combination with mitotane in patients with metastatic adrenocortical cancer","volume":"3","author":"Head","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.jsbmb.2024.106462_bib16","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1530\/EC-18-0398","article-title":"Immunotherapy failure in adrenocortical cancer: where next?","volume":"7","author":"Cosentini","year":"2018","journal-title":"Endocr. Connect"},{"key":"10.1016\/j.jsbmb.2024.106462_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001009","article-title":"Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma","volume":"8","author":"Bedrose","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jsbmb.2024.106462_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jsbmb.2024.106462_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41577-020-00464-0","article-title":"Glucocorticoids in T cell development, differentiation and function","volume":"21","author":"Taves","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jsbmb.2024.106462_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000469","article-title":"Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma","volume":"8","author":"Landwehr","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jsbmb.2024.106462_bib21","doi-asserted-by":"crossref","first-page":"10061","DOI":"10.1111\/jcmm.16936","article-title":"Integrative computational immunogenomic profiling of cortisol-secreting adrenocortical carcinoma","volume":"25","author":"Baechle","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.jsbmb.2024.106462_bib22","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.3390\/cancers14092152","article-title":"Tumor microenvironment in mixed neuroendocrine non-neuroendocrine neoplasms: interaction between tumors and immune cells, and potential effects of neuroendocrine differentiation on the tumor microenvironment","volume":"14","author":"Tsunokake","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jsbmb.2024.106462_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/cjp2.179","article-title":"Digital image analysis in pathologist-selected regions of interest predicts survival more accurately than whole-slide analysis: a direct comparison study in 153 gastric carcinomas","volume":"7","author":"Heo","year":"2021","journal-title":"J. Pathol. Clin. Res"},{"key":"10.1016\/j.jsbmb.2024.106462_bib24","doi-asserted-by":"crossref","first-page":"8275","DOI":"10.2147\/CMAR.S255816","article-title":"Digital image analysis of CD8+ and CD3+ tumor-infiltrating lymphocytes in tongue squamous cell carcinoma","volume":"12","author":"Huang","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.jsbmb.2024.106462_bib25","article-title":"MET overexpression in EGFR L858R mutant treatment-na\u00efve advanced lung adenocarcinoma correlated with poor prognosis: a real-world retrospective study","author":"Wang","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2024.106462_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1349-7006.2008.01015.x","article-title":"Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis","volume":"100","author":"Tamaki","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jsbmb.2024.106462_bib27","first-page":"5265","article-title":"Expression of vasohibin\u20111 and\u20112 predicts poor prognosis among patients with squamous cell carcinoma of the esophagus","volume":"16","author":"Ninomiya","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jsbmb.2024.106462_bib28","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1016\/S1470-2045(16)30123-1","article-title":"Novel therapeutic targets on the horizon for lung cancer","volume":"17","author":"Tan","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jsbmb.2024.106462_bib29","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jsbmb.2024.106462_bib30","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMe1006416","article-title":"Treating cancer by targeting the immune system","volume":"363","author":"Hwu","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2024.106462_bib31","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.jsbmb.2024.106462_bib32","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1200\/JCO.2006.05.9584","article-title":"Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse","volume":"24","author":"Bates","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2024.106462_bib33","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3389\/fimmu.2020.01731","article-title":"Redefining tumor-associated macrophage subpopulations and functions in the tumor microenvironment","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jsbmb.2024.106462_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173090","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Yunna","year":"2020","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.jsbmb.2024.106462_bib35","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.immuni.2020.08.005","article-title":"Endogenous glucocorticoid signaling regulates CD8(+) T cell differentiation and development of dysfunction in the tumor microenvironment","volume":"53","author":"Acharya","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jsbmb.2024.106462_bib36","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/ijc.32080","article-title":"Differential effects of corticosteroids and anti-TNF on tumor-specific immune responses: implications for the management of irAEs","volume":"145","author":"Draghi","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jsbmb.2024.106462_bib37","first-page":"453","article-title":"Macrophage activation and polarization","volume":"13","author":"Martinez","year":"2008","journal-title":"FBL"},{"key":"10.1016\/j.jsbmb.2024.106462_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/clinchem\/hvac191","article-title":"In situ metabolomics of cortisol-producing adenomas","volume":"69","author":"Murakami","year":"2023","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jsbmb.2024.106462_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105764","article-title":"Intratumoral heterogeneity of the tumor cells based on in situ cortisol excess in cortisol-producing adenomas; \u223can association among morphometry, genotype and cellular senescence\u223c","volume":"204","author":"Gao","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2024.106462_bib40","article-title":"The effect of hormonal secretion on survival in adrenocortical carcinoma: a multi-center study","author":"Sada","year":"2023","journal-title":"Surgery"},{"key":"10.1016\/j.jsbmb.2024.106462_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2741\/2441","article-title":"Impact of androgen-deprivation therapy on the immune system: implications for combination therapy of prostate cancer","volume":"12","author":"Aragon-Ching","year":"2007","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jsbmb.2024.106462_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010020","article-title":"The response of prostate cancer to androgen deprivation and irradiation due to immune modulation","volume":"11","author":"Wu","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jsbmb.2024.106462_bib43","first-page":"329","article-title":"Vascularity in human adrenal cortex","volume":"11","author":"Sasano","year":"1998","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jsbmb.2024.106462_bib44","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s12253-017-0259-6","article-title":"Angiogenesis and lymphangiogenesis in the adrenocortical tumors","volume":"24","author":"Pereira","year":"2018","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.jsbmb.2024.106462_bib45","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.humpath.2013.10.028","article-title":"The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma","volume":"45","author":"Murakami","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jsbmb.2024.106462_bib46","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.humpath.2013.09.024","article-title":"Angiogenesis and vascular maturation in neuroendocrine tumors","volume":"45","author":"Yazdani","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jsbmb.2024.106462_bib47","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3892\/mmr.2014.2914","article-title":"Ki67 is a promising molecular target in the diagnosis of cancer (review)","volume":"11","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jsbmb.2024.106462_bib48","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/00000478-200212000-00009","article-title":"Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors","volume":"26","author":"Aubert","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jsbmb.2024.106462_bib49","first-page":"2193","article-title":"Tumour infiltrating lymphocytes in colorectal cancers- correlation with tumour biology and clinical outcome: a cohort study","volume":"72","author":"Mangi","year":"2022","journal-title":"J. Pak. Med. Assoc."},{"key":"10.1016\/j.jsbmb.2024.106462_bib50","article-title":"The association between CD3(+) and CD8(+)tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic adenocarcinoma","volume":"35","author":"Panahi","year":"2023","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.jsbmb.2024.106462_bib51","doi-asserted-by":"crossref","first-page":"314","DOI":"10.30699\/ijp.2022.539946.2737","article-title":"Crosstalk between programmed death ligand 1, Ki-67 labelling index, and tumor-infiltrating lymphocytes in invasive breast cancer and clinicopathological correlations in a tertiary care center in Western India","volume":"17","author":"Sharma","year":"2022","journal-title":"Iran. J. Pathol."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076024000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076024000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T16:35:14Z","timestamp":1778517314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076024000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":51,"alternative-id":["S0960076024000104"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2024.106462","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histopathological analysis of tumor microenvironment in adrenocortical carcinoma: Possible effects of in situ disorganized glucocorticoid production on tumor immunity","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2024.106462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106462"}}